Exchange transfusion in neonatal hyperbilirubinaemia: Experience in Isfahan, Iran

Singapore Medical Journal

Volumn 48, Issue 5, 2007, Pages 421-423

  Badiee, Zohreh ^a  

^a ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Blood transfusion; Exchange transfusion; Hyperbilirubinaemia; Neonate hyperbilirubinaemia; Thrombocytopenia

Indexed keywords

BILIRUBIN; GLUCOSE 6 PHOSPHATE DEHYDROGENASE;

ARTICLE; BILIRUBIN BLOOD LEVEL; BLOOD GROUP ABO INCOMPATIBILITY; EXCHANGE BLOOD TRANSFUSION; EXPERIENCE; FATALITY; HUMAN; HYPERBILIRUBINEMIA; IRAN; MAJOR CLINICAL STUDY; MEDICAL RECORD; NEWBORN; PERINATAL CARE; RETROSPECTIVE STUDY; THROMBOCYTOPENIA; NEWBORN JAUNDICE;

EXCHANGE TRANSFUSION, WHOLE BLOOD; HUMANS; HYPERBILIRUBINEMIA, NEONATAL; INFANT, NEWBORN;

EID: 34249698335     PISSN: 00375675     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Abu-Ekteish F, Daoud A, Rimawi H, Kakish K, Abu-Heija A. Neonatal exchange transfusion: a Jordanian experience. Ann Trop Paediatr 2000; 20:57-60.
2. Stockman JA 3rd. Overview of the state of the art of Rh disease: history, current clinical management, and recent progress. J Pediatr Hematol Oncol 2001; 23:385-93. Erratum in: J Pediatr Hematol Oncol 2001; 23:549.
3. Dennery PA, Seidman PS, Stevenson DK. Neonatal hyperbilirubinemia. N Engl J Med 2001; 344:581-90.
4. Watchko JF, Oski FA. Bilirubin 20 mg/dL = vigintiphobia. Pediatrics 1983; 71:660-3.
5. Newman TB, Maisels MJ. Evaluation and treatment of jaundice in the term newborn: a kinder, gentler approach. Pediatrics 1992; 89:809-18. Comment in: Pediatrics 1992; 89:819-31. Pediatrics 1993; 91:166-7; author reply 168. Pediatrics 1993; 91:1218-9.
6. Jackson JC. Adverse events associated with exchange transfusion in healthy and ill newborns. Pediatrics 1997; 99:E7.
7. Boggs TR, Westphal MC. Mortality of exchange transfusion. Pediatrics 1960; 26:745-55.
8. Weldon VV, Odell GB. Mortality risk of exchange transfusion. Pediatrics 1968; 41:797-801.
9. Panagopoulos G, Valaes T, Doxiadis SA. Morbidity and mortality related to exchange transfusions. J Pediatr 1969; 74:247-54.
10. Kitchen WH. Neonatal mortality in infants receiving an exchange transfusion. Aust Paediatr J 1970; 6:30-40.
11. Hovi L, Siimes MA. Exchange transfusion with fresh heparinized blood is a safe procedure. Experiences from 1 069 newborns. Acta Paediatr Scand 1985; 74:360-5.
12. Dikshit SK, Gupta PK. Exchange transfusion in neonatal hyper - bilirubinemia. Indian Pediatr 1989; 26:1139-45.
13. Guaran RL, Drew JH, Watkins AM. Jaundice: clinical practice in 88,000 liveborn infants. Aust N Z J Obstet Gynaecol 1992; 32:186-92.
14. Keenan WJ, Novak KK, Sutherland JM, Bryla DA, Fetterly KL. Morbidity and mortality associated with exchange transfusion. Pediatrics 1985; 75:417-21.
15. Chima RS, Johnson LH, Bhutani VK. Evaluation of adverse events due to exchange transfusion in term and near-term newborns. Pediatr Res 2001; 49:324A.
16. Bell MJ, Ternberg JL, Feigin RD, et al. Neonatal necrotizing enterocolitis. Therapeutic decisions based upon clinical staging. Ann Surg 1978; 187:1-7.
17. Funato M, Tamai H, Shimada S. Trends in neonatal exchange transfusions at Yodogawa Christian Hospital. Acta Pediatr Jpn 1997; 39:305-8.
18. Lucey JF. Neonatal jaundice and phototherapy. Pediatr Clin North Am 1972; 19:827-39.
19. Woodrow JC. Effectiveness of Rh prophylaxis. Haematologica (Budap) 1974; 8:281-90.
20. Sanpavat S. Exchange transfusion and its morbidity in ten-year period at King Chulalongkorn Hospital. J Med Assoc Thai 2005; 88:588-92.
21. Madanat F, Karadsheh N, Shamayleh A, et al. Glucose-6-phosphate dehydrogenase deficiency in male newborns. Jordan Med J 1986; 21:205-12.
22. Tan KL. Glucose-6-phosphate dehydrogenase status and neonatal jaundice. Arch Dis Child 1981; 56:874-7.
23. Patra K, Storfer-Isser A, Siner B, Moore J, Hack M. Adverse events associated with neonatal exchange transfusion in the 1990s. J Pediatr 2004; 144:626-31.